GlaxoSmithKline

GlaxoSmithKline

Verified
Science-led global healthcare co with a special purpose: to help people to do more, feel better, live longer

Launch date
Employees
Market cap
$102.1b
Net debt
£10.3b
Firm valuation
$114.5b (Public information from Aug 2022)
Brentford England (HQ)

Financials

Edit
Revenues, earnings & profits over time
EUR2016201720182019202020212022E
Revenues-36.2b37.0b40.5b40.9b40.9b43.3b
% growth--2 %10 %1 %-6 %
EBITDA(10m)12.3b12.6b14.4b11.4b13.6b13.0b
% EBITDA margin-34 %34 %35 %28 %33 %30 %
Profit10m1.8b4.3b5.6b6.9b5.3b6.6b
% profit margin-5 %12 %14 %17 %13 %15 %
EV / revenue-2.6x3.1x3.4x2.6x2.9x2.6x
EV / EBITDA-7.6x9.0x9.5x9.2x8.8x8.8x
R&D budget4.0b4.4b4.1b5.1b---
R&D % of revenue-12 %11 %13 %---

Source: Company fillings or news article

  • Edit
DateInvestorsAmountRound
-N/A-
Not yet verified
N/AN/AIPO
Not yet verified
N/A$7.5mGrant
Not yet verified
N/A$18mGrant
Not yet verified
Total Funding-

Recent News about GlaxoSmithKline

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit
  • Edit
GlycoVaxyn
ACQUISITION by GlaxoSmithKline Feb 2015
Sirtris Pharmaceuticals
ACQUISITION by GlaxoSmithKline Apr 2008
Corixa
ACQUISITION by GlaxoSmithKline May 2005
Semprus BioSciences
ACQUISITION by Teleflex Jun 2012
Anacor Pharmaceutical
ACQUISITION by Pfizer May 2016
Human Genome Sciences
ACQUISITION by GlaxoSmithKline Aug 2012
View 116 more